Market Research Logo

Myanmar Pharmaceuticals and Healthcare Report Q2 2016

Myanmar Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The influx of private healthcare providers into Myanmar will continue, creating positive spillovereffects for both medical device and pharmaceutical firms. This attraction is due to the combination of alarge unmet demand for medical services in the country, as well as the development of healthcare financing,such as the introduction of private medical insurance. Due to its geographic proximity, Thailand-basedhealthcare providers are expected to be the most active in expanding into this frontier market.

Headline Expenditure Projections

Pharmaceutical sales: MMK458.3bn (USD390mn) in 2015 to MMK536.8bn (USD400mn) in 2015;+17.1% in local currency terms and +2.9% in US dollar terms. Forecast downwards from last quarter.

Healthcare Expenditure: MMK1,176.8bn (USD1.01bn) in 2015 to MMK1,304.8bn (USD980mn) in2016; +10.9% in local currency terms and -2.6% in US dollar terms. Forecast revised downwards fromlast quarter, growth in USD terms affected by exchange rates.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Myanmar 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Myanmar 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Myanmar 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Myanmar 2014-2020)
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
Myanmar Risk/Reward Index
Rewards
Risks
Regulatory Review
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Communicable Diseases And Other Injuries
Non-Communicable Diseases
Competitive Landscape
Table: Table: Multinational Market Activity
Company Profile
Fame Pharmaceutical
Mega Lifesciences
Demographic Forecast
Table: Population Headline Indicators (Myanmar 1990-2025)
Table: Key Population Ratios (Myanmar 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Myanmar 1990-2025)
Table: Population By Age Group (Myanmar 1990-2025)
Table: Population By Age Group % (Myanmar 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report